XTL Biopharmaceuticals Ltd ADR Net Asset Quality Index
XTL Biopharmaceuticals Ltd ADR net asset quality index. XTL Biopharmaceuticals Ltd ADR (XTLB) has a Net Asset Quality Index of -153.0% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $166.00K minus total liabilities of $420.00K yields net assets of $-254.00K. A higher index indicates a stronger, lower-leverage balance sheet. See net assets of XTL Biopharmaceuticals Ltd ADR for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of XTL Biopharmaceuticals Ltd ADR (2002–2025)
Net asset quality index of XTL Biopharmaceuticals Ltd ADR from 2002 to 2025. This chart shows how XTL Biopharmaceuticals Ltd ADR's Net Asset Quality Index has evolved across 24 annual periods from 2002 to 2025. As of March 2026, the index stands at -153.0%, representing net assets of $-254.00K against total assets of $166.00K USD. Check XTLB PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
XTL Biopharmaceuticals Ltd ADR Net Asset Quality Index by Year (2002–2025)
XTL Biopharmaceuticals Ltd ADR net asset quality index by year from 2002 to 2025. The table below presents the year-by-year Net Asset Quality Index for XTL Biopharmaceuticals Ltd ADR from 2002 to 2025, covering 24 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see XTLB stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -153.0% | $-254.00K | $166.00K | $420.00K | ▼ -216.6 pp |
| 2024 | 63.6% | $5.43 Million | $8.55 Million | $3.12 Million | ▼ -27.9 pp |
| 2023 | 91.5% | $2.22 Million | $2.43 Million | $206.00K | ▼ -4.0 pp |
| 2022 | 95.5% | $4.00 Million | $4.19 Million | $187.00K | ▲ +14.9 pp |
| 2021 | 80.6% | $5.33 Million | $6.62 Million | $1.28 Million | ▼ -15.5 pp |
| 2020 | 96.1% | $6.25 Million | $6.50 Million | $254.00K | ▼ -0.7 pp |
| 2019 | 96.8% | $6.98 Million | $7.21 Million | $232.00K | ▼ -0.3 pp |
| 2018 | 97.0% | $8.32 Million | $8.57 Million | $253.00K | ▲ +42.1 pp |
| 2017 | 54.9% | $3.62 Million | $6.59 Million | $2.97 Million | ▼ -34.1 pp |
| 2016 | 89.1% | $2.69 Million | $3.02 Million | $330.00K | ▼ -2.7 pp |
| 2015 | 91.8% | $4.89 Million | $5.32 Million | $436.00K | ▲ +8.9 pp |
| 2014 | 82.9% | $4.68 Million | $5.64 Million | $965.00K | ▼ -1.8 pp |
| 2013 | 84.7% | $6.79 Million | $8.02 Million | $1.23 Million | ▼ -0.4 pp |
| 2012 | 85.0% | $9.42 Million | $11.09 Million | $1.66 Million | ▲ +0.5 pp |
| 2011 | 84.6% | $3.44 Million | $4.07 Million | $629.00K | ▲ +9.9 pp |
| 2010 | 74.6% | $2.83 Million | $3.80 Million | $963.00K | ▲ +73.7 pp |
| 2009 | 1.0% | $7.00K | $715.00K | $708.00K | ▼ -40.6 pp |
| 2008 | 41.6% | $1.43 Million | $3.43 Million | $2.00 Million | ▼ -19.0 pp |
| 2007 | 60.6% | $8.56 Million | $14.13 Million | $5.56 Million | ▼ -24.0 pp |
| 2006 | 84.6% | $22.76 Million | $26.90 Million | $4.14 Million | ▲ +10.3 pp |
| 2005 | 74.3% | $11.25 Million | $15.15 Million | $3.90 Million | ▼ -2.2 pp |
| 2004 | 76.5% | $19.60 Million | $25.62 Million | $6.02 Million | ▼ -6.4 pp |
| 2003 | 82.9% | $20.61 Million | $24.85 Million | $4.25 Million | ▼ -7.7 pp |
| 2002 | 90.6% | $34.83 Million | $38.42 Million | $3.59 Million | — |